| 1 |
33129112 | Anti-epidermal growth factor vaccine antibodies increase the antitumor activity of kinase inhibitors in ALK and RET rearranged lung cancer cells. | 2021 Jan |
1 |
| 2 |
33569315 | Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET). | 2021 Jan |
4 |
| 3 |
33728771 | The ALK inhibitors, alectinib and ceritinib, induce ALK-independent and STAT3-dependent glioblastoma cell death. | 2021 Jun |
1 |
| 4 |
34225542 | An overview of alectinib hydrochloride as a treatment option for ALK positive non-small cell lung cancer. | 2021 Oct |
1 |
| 5 |
34803090 | Severe Skin Toxicity Caused by Sequential Anti-PD-1 Antibody and Alectinib in Non-small-cell Lung Cancer: A Report of Two Cases and a Literature Review. | 2021 Nov 20 |
3 |
| 6 |
31698333 | Alectinib activity in chemotherapy-refractory metastatic RET-rearranged non-small cell lung carcinomas: A case series. | 2020 Jan |
4 |
| 7 |
32835580 | Enhanced antitumor effect of alectinib in combination with cyclin-dependent kinase 4/6 inhibitor against RET-fusion-positive non-small cell lung cancer cells. | 2020 Sep 1 |
5 |
| 8 |
32882995 | Novel Multitarget Therapies for Lung Cancer and Respiratory Disease. | 2020 Sep 1 |
1 |
| 9 |
29912274 | Selective RET kinase inhibition for patients with RET-altered cancers. | 2018 Aug 1 |
1 |
| 10 |
28629549 | Intracranial and Systemic Response to Alectinib in a Patient with RET-KIF5B Oncogenic Fusion. | 2017 Jul |
1 |
| 11 |
28955006 | Phase I/II study of alectinib in lung cancer with RET fusion gene: study protocol. | 2017 |
4 |
| 12 |
29088743 | In vitro and in vivo anti-tumor activity of alectinib in tumor cells with NCOA4-RET. | 2017 Sep 26 |
10 |
| 13 |
27544060 | Clinical Activity of Alectinib in Advanced RET-Rearranged Non-Small Cell Lung Cancer. | 2016 Nov |
8 |
| 14 |
26798590 | Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine? | 2015 Dec |
3 |
| 15 |
25349307 | Alectinib shows potent antitumor activity against RET-rearranged non-small cell lung cancer. | 2014 Dec |
9 |